Key regions: Canada, United States, France, Europe, United Kingdom
The Skin Treatment (Pharmacies) market in Europe is experiencing steady growth and development.
Customer preferences: Customers in Europe are increasingly prioritizing skincare and are willing to invest in high-quality skin treatment products. They are becoming more conscious of the importance of skincare and are actively seeking products that address their specific skin concerns. Additionally, there is a growing demand for natural and organic skincare products, as customers are becoming more aware of the potential harmful effects of certain chemicals and ingredients.
Trends in the market: One of the key trends in the Skin Treatment (Pharmacies) market in Europe is the rise of personalized skincare. Customers are seeking products that are tailored to their individual needs and preferences. This has led to the development of customizable skincare solutions, where customers can choose specific ingredients or formulations based on their skin type and concerns. This trend is driven by advancements in technology and the availability of data that allows for personalized recommendations. Another trend in the market is the increasing popularity of multi-step skincare routines. Customers are adopting the Korean skincare approach, which involves multiple steps such as cleansing, toning, moisturizing, and applying targeted treatments. This trend has led to a higher demand for a wide range of skincare products, including serums, essences, and masks.
Local special circumstances: In Europe, there are specific regulations and standards that govern the skincare industry. The European Union has implemented strict regulations on the use of certain ingredients in skincare products, ensuring the safety and efficacy of these products. This has resulted in a higher level of trust and confidence among customers in the skincare products available in pharmacies.
Underlying macroeconomic factors: The growing skincare market in Europe is also influenced by macroeconomic factors. The region has a relatively high disposable income, allowing customers to spend more on skincare products. Additionally, the aging population in Europe has contributed to the growth of the skincare market, as older individuals are more likely to invest in anti-aging and skin rejuvenation treatments. In conclusion, the Skin Treatment (Pharmacies) market in Europe is developing due to changing customer preferences, such as the demand for personalized skincare and multi-step skincare routines. The local special circumstances, including strict regulations and standards, also contribute to the growth of the market. Furthermore, underlying macroeconomic factors, such as high disposable income and an aging population, play a role in driving the development of the market.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
